✦ LIBER ✦

Do we know how to achieve optimal response to Pegylated interferon alpha and Ribavirin?

✍ Scribed by Jenny Heathcote

Book ID: 117371891
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 81 KB
Volume: 39
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)00197-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C treatment in “difficult-to-t

Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects

✍ Martin Schaefer; Axel Hinzpeter; Ariane Mohmand; Gesa Janssen; Maurice Pich; Mar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

We investigated and compared the results of treating the chronic hepatitis C (HCV) infection of different groups of psychiatric-risk patients and controls with pegylated interferon alpha (pe-gIFN-␣) plus ribavirin. Seventy patients were prospectively screened for psychiatric disorders. Seventeen pat

Influence of HLA alleles in response to

Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C

✍ A. V. Marangon; R. A. Moliterno; A. M. Sell; C. F. V. de Moraes; R. M. T. Grotto 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Optimal follow-up time to determine the

Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin

✍ Masashi Namikawa; Satoru Kakizaki; Yutaka Yata; Yuichi Yamazaki; Norio Horiguchi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Hepatitis C virus RNA kinetics during th

Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response

✍ T. Carlsson; O. Reichard; G. Norkrans; J. Bläckberg; P. Sangfelt; E. Wallmark; O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Association of IL28B variants with respo

Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b

✍ Naoya Sakamoto; Mina Nakagawa; Yasuhito Tanaka; Yuko Sekine-Osajima; Mayumi Ueya 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Abstract Genetic polymorphisms of the interleukin 28B (IL28B) locus are associated closely with outcomes of pegylated‐interferon (PEG‐IFN) plus ribavirin (RBV) combination therapy. The aim of this study was to investigate the relationship between IL28B polymorphism and responses to therapy in pa

Mutations in the interferon sensitivity

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

✍ Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yas 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 266 KB